Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 14:13:1013362.
doi: 10.3389/fendo.2022.1013362. eCollection 2022.

The effects of season (spring versus autumn) on diagnosis of normocalcemic primary hyperparathyroidism

Magdalena Basińska-Lewandowska  1 , Andrzej Lewiński  2   3 , Krzysztof C Lewandowski  2   3 , Elżbieta Skowrońska-Jóźwiak  2   3
Affiliations

The effects of season (spring versus autumn) on diagnosis of normocalcemic primary hyperparathyroidism

Magdalena Basińska-Lewandowska et al. Front Endocrinol (Lausanne). .

Abstract

Background: Raised parathormone (PTH) and normal calcium concentrations can be observed both in normocalcemic primary hyperparathyroidism (nPHPT) and in secondary hyperparathyroidism, e.g. due to vitamin D deficiency. We assessed the impact of season on the validity of diagnosis of nPHPT in terms of screening investigations to be performed in the primary care settings.

Material and methods: On two occasions (March/April & September/October) we measured vitamin D (25OHD), PTH and total calcium in 125 healthy subjects, age range 6-50, not taking any vitamin D supplements.

Results: In autumn there was an increase in 25OHD concentrations (from 18.1 ± 7.37ng/ml to 24.58 ± 7.72ng/ml, p<0.0001), a decline in PTH from 44.40 ± 17.76pg/ml to 36.63 ± 14.84pg/ml, p<0.001), without change in calcium levels. Only 45 subjects (36%) were vitamin D sufficient (25OHD>20/ml) in spring versus 83 (66.4%) in autumn, p<0.001. Elevated PTH concentrations were noted in 10 subjects in spring (8%) and in six subjects (4.8%) (p<0.05) in autumn. In spring, however, eight out of ten of these subjects (80%) had 25OHD<20 ng/ml, versus one in six (16.7%) in autumn (p<0.01). Normalization of PTH was observed in seven out ten subjects (70%), and all of them had 25-OHD<20 ng/ml in spring.

Conclusions: In spring elevated PTH concentrations in the setting of normocalcemia are more likely to be caused by 25OHD deficiency rather by nPHPT. In contrast, in autumn, increased PTH concentrations are more likely to reflect nPHPT. We postulate that screening for nPHPT should be done in 25OHD replete subjects, i.e. in autumn rather than in spring.

Keywords: 25OHD; PTH; normocalcemic primary hyperparathyroidism; screening; vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, et al. . Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab (2013) 98(3):1122–9. doi: 10.1210/jc.2012-4022 - DOI - PMC - PubMed
    1. Pawłowska M, Cusano NE. An overview of normocalcemic primary hyperparathyroidism. Curr Opin Endocrinol Diabetes Obes (2015) 22(6):413–21. doi: 10.1097/MED.0000000000000198 - DOI - PubMed
    1. Eastell R, Arnold A, Brandi ML, D'Amour P, Hanley DA, Sudhaker Rao D, et al. . Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 94(2):340–50. doi: 10.1210/jc.2008-1758 - DOI - PubMed
    1. Salcuni AS, Battista C, Pugliesie F, Columbu C, Guarnieri V, Carnevale V, et al. . Normocalcemic primary hyperparathyroidism: an update. Minerva Endocrinol (Torino) (2021) 46(3):262–71. doi: 10.23736/S0391-1977.20.03215-0 - DOI - PubMed
    1. Aojula N, Khan S, Gittoes N, Hassan-Smith Z. Normocalcaemic primary hyperparathyroidism: What is the role of parathyroid surgery? Therap Adv Endocrinol Metab (2021) 12:1–10. doi: 10.1177/2042018821995370 - DOI - PMC - PubMed

Publication types